SOAT1 and pneumonia: Although the exact mechanisms of anti-inflammatory therapy for influenza pneumonia are not yet fully understood, our research suggests that JAK-STAT signaling pathways are potential anti-inflammatory drug targets, and JAK inhibitors have great potential to be a new and safe class of anti-inflammatory agents for treating influenza pneumonia.